Literature DB >> 19264952

Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury.

Satoshi Kuboki1, Nozomu Sakai, Johannes Tschöp, Michael J Edwards, Alex B Lentsch, Charles C Caldwell.   

Abstract

Helper T cells are known to mediate hepatic ischemia/reperfusion (I/R) injury. However, the precise mechanisms and subsets of CD4(+) T cells that contribute to this injury are still controversial. Therefore, we sought to determine the contributions of different CD4(+) T cell subsets during hepatic I/R injury. Wild-type, OT-II, or T cell receptor (TCR)-delta-deficient mice were subjected to 90 min of partial hepatic ischemia followed by 8 h of reperfusion. Additionally, wild-type mice were pretreated with anti-CD1d, -NK1.1, or -IL-2R-alpha antibodies before I/R injury. OT-II mice had diminished liver injury compared with wild-type mice, implicating that antigen-dependent activation of CD4(+) T cells through TCRs is involved in hepatic I/R injury. TCR-delta knockout mice had decreased hepatic neutrophil accumulation, suggesting that gammadelta T cells regulate neutrophil recruitment. We found that natural killer T (NKT) cells, but not NK cells, contribute to hepatic I/R injury via CD1d-dependent activation of their TCRs, as depletion of NKT cells by anti-CD1d antibody or depletion of both NKT cells and NK cells by anti-NK1.1 attenuated liver injury. Although regulatory T cells (Treg) are known to suppress T cell-dependent inflammation, depletion of Treg cells had little effect on hepatic I/R injury. The data suggest that antigen-dependent activation of CD4(+) T cells contributes to hepatic I/R injury. Among the subsets of CD4(+) T cells, it appears that gammadelta T cells contribute to neutrophil recruitment and that NKT cells directly injure the liver. In contrast, NK cells and Treg have little effects on hepatic I/R injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264952      PMCID: PMC2696215          DOI: 10.1152/ajpgi.90464.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  42 in total

Review 1.  Toward an understanding of NKT cell biology: progress and paradoxes.

Authors:  Mitchell Kronenberg
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 2.  The integration of conventional and unconventional T cells that characterizes cell-mediated responses.

Authors:  Daniel J Pennington; David Vermijlen; Emma L Wise; Sarah L Clarke; Robert E Tigelaar; Adrian C Hayday
Journal:  Adv Immunol       Date:  2005       Impact factor: 3.543

3.  Divergent functions of CD4+ T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion.

Authors:  Charles C Caldwell; Tomohisa Okaya; Andre Martignoni; Thomas Husted; Rebecca Schuster; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-07-07       Impact factor: 4.052

4.  Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

Authors:  S Onizuka; I Tawara; J Shimizu; S Sakaguchi; T Fujita; E Nakayama
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

5.  CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver.

Authors:  R M Zwacka; Y Zhang; J Halldorson; H Schlossberg; L Dudus; J F Engelhardt
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

6.  Distinct and sequential upregulation of genes regulating cell growth and cell cycle progression during hepatic ischemia-reperfusion injury.

Authors:  Sharon Barone; Tomohisa Okaya; Steve Rudich; Snezana Petrovic; Kathy Tenrani; Zhaohui Wang; Kamyar Zahedi; Robert A Casero; Alex B Lentsch; Manoocher Soleimani
Journal:  Am J Physiol Cell Physiol       Date:  2005-05-11       Impact factor: 4.249

7.  Role of the T-cell receptor in kidney ischemia-reperfusion injury.

Authors:  V Savransky; R R Molls; M Burne-Taney; C-C Chien; L Racusen; H Rabb
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

8.  Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC.

Authors:  A B Lentsch; H Yoshidome; W G Cheadle; F N Miller; M J Edwards
Journal:  Hepatology       Date:  1998-04       Impact factor: 17.425

9.  Protective effect of cyclosporine A (CyA) against the hepatic injury associated with ischemia and reperfusion.

Authors:  M F Sakr; A N Abdel-Aal
Journal:  Int Surg       Date:  1996 Apr-Jun

10.  Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation.

Authors:  G A Wanner; W Ertel; P Müller; Y Höfer; R Leiderer; M D Menger; K Messmer
Journal:  Shock       Date:  1996-01       Impact factor: 3.454

View more
  34 in total

1.  Interleukin-22: implications for liver ischemia-reperfusion injury.

Authors:  Paul J Chestovich; Yoichiro Uchida; William Chang; Mark Ajalat; Charles Lassman; Robert Sabat; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Transplantation       Date:  2012-03-15       Impact factor: 4.939

Review 2.  Regulatory T cells in AKI.

Authors:  Gilbert R Kinsey; Rahul Sharma; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

Review 3.  Role of NK, NKT cells and macrophages in liver transplantation.

Authors:  René Fahrner; Felix Dondorf; Michael Ardelt; Utz Settmacher; Falk Rauchfuss
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

4.  Receptor activator of nuclear factor-κB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice.

Authors:  Nozomu Sakai; Heather L Van Sweringen; Rebecca Schuster; John Blanchard; Justin M Burns; Amit D Tevar; Michael J Edwards; Alex B Lentsch
Journal:  Hepatology       Date:  2012-01-13       Impact factor: 17.425

Review 5.  Innate T cells in the intensive care unit.

Authors:  Edy Yong Kim; William M Oldham
Journal:  Mol Immunol       Date:  2018-12-13       Impact factor: 4.407

Review 6.  Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation.

Authors:  Y Zhai; R W Busuttil; J W Kupiec-Weglinski
Journal:  Am J Transplant       Date:  2011-06-10       Impact factor: 8.086

Review 7.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

8.  Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

Authors:  Yuanxing Liu; Haofeng Ji; Yu Zhang; Xiuda Shen; Feng Gao; Xiangyi He; Gabriella A Li; Ronald W Busuttil; Vijay K Kuchroo; Jerzy W Kupiec-Weglinski
Journal:  J Hepatol       Date:  2014-10-31       Impact factor: 25.083

9.  Tumor Necrosis Factor-α: Life and Death of Hepatocytes During Liver Ischemia/Reperfusion Injury.

Authors:  Maureen Shuh; Humberto Bohorquez; George E Loss; Ari J Cohen
Journal:  Ochsner J       Date:  2013

Review 10.  T cells in organ ischemia reperfusion injury.

Authors:  Jianhua Rao; Ling Lu; Yuan Zhai
Journal:  Curr Opin Organ Transplant       Date:  2014-04       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.